04 March 2021
A new UK study will seek to understand the immune response to COVID-19 vaccinations in patients with certain immunosuppressed conditions.
The trial, called the OCTAVE trial, is funded by the Medical Research Council (MRC), and is a collaborative research project involving groups in the Universities of Glasgow, Birmingham, Oxford, Liverpool, Imperial College London and Leeds Teaching Hospitals NHS Trust.
Patients with end stage kidney disease have a poor prognosis following infection with COVID, with one in every five infected dialysis patients in the UK having died. Dr Michelle Willicombe Imperial study co-lead
Researchers will build on years of experience in understanding the immune system in the context of chronic conditions, to better determine the effectiveness of COVID-19 vaccines in these clinically at-risk patient groups.
New study into Covid vaccine responses in patients with impaired immune systems oxfordmail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from oxfordmail.co.uk Daily Mail and Mail on Sunday newspapers.
People with cancer, inflammatory arthritis, liver or kidney disease and those who are having a stem cell transplant may be at increased risk of Covid infection.
Urgent study into whether Covid vaccines work for people with cancer grimsbytelegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from grimsbytelegraph.co.uk Daily Mail and Mail on Sunday newspapers.